Please use this identifier to cite or link to this item: http://sgc.anlis.gob.ar/handle/123456789/2695
Title: Effectiveness of infection control measures informed by a modified Blue-Carba test in reducing rectal carriage of carbapenemase-producing bacteria in general wards: a prospective interrupted time series study
Authors: Castro, G. M. 
Argarañá, Fernanda 
Bernasconi, Carla 
Margenet, Leticia 
Amato, Ana Paula 
Coduri Anthonioz Blanc, Joaquín Ignacio 
Rottoli, Erwin Alexander 
Protto, Manuel 
Vicino, Macarena 
Sadonio, María José 
Galluccio, Federico Rafael 
Musacchio, Héctor Mario 
Pasteran, Fernando 
Gómez, Sonia Alejandra 
Keywords: Sensibilidad y Especificidad;Estudios Prospectivos;Prevalencia;Algoritmos;Argentina;Bacterias;Hospitales;Tamizaje Masivo
Issue Date: 4-Sep-2025
Abstract: 
Introduction: The spread of carbapenemase-producing bacteria (CPB) is
exacerbated in hospital settings, making the surveillance of rectal carriage of
CPB crucial to halt their spread. However, the processing time until detection
with traditional methods and the cost of new techniques limit their
implementation. We aimed to evaluate the effectiveness of infection
prevention and control (IPC) measures guided by a novel algorithm (NA) for
rectal swab processing, which incorporated a modified Blue-Carba test (mBCT),
in reducing carbapenemase-producing bacteria (CPB) rectal carriage prevalence
in general wards of a tertiary-care hospital from Argentina. Additionally, we
assessed the impact of this algorithm on microbiological turnaround time
(mTAT) and time to positive results (TPR).
Materials and methods: An experimental and quasi-experimental designs were
combined into a prospective interrupted time series study structured in three
phases: P1 (February 2022-July 2022), P2 (August 2022-January 2023;
intervention) and P3 (February 2023-July 2023). Briefly, the NA included as
key steps a 6-hour pre-incubation at 37 °C in nutrient broth, followed by a
15-minute centrifugation at 3,200 rpm. The mBCT was set at pH 10.7 using 9 mg
of imipenem in a final volume of 150 μL and was validated against conventional
methods testing 1,120 samples. It was subsequently implemented to assess its
impact on hospital CPB prevalence and the effectiveness of IPC measures. Patients
were randomly selected for CPB rectal screening during Phases 1 and 3 and
provided informed consent for inclusion.
Results: The mBCT significantly shortened the mTAT and TPR compared to
standard approaches (<24 h vs. 4d, p < 0.001), showing moderate sensitivity
[54.6% (IC95% 45.2–63.7)] and high specificity [99.8% (IC 95% 99.3–100)]. The
IPC intervention guided by the mBCT reduced CPB prevalence in general wards
(8.1% vs. 13.8%, p = 0.006).
Conclusion: The implementation of the NA reduced mTAT with high sensitivity,
while the mBCT also contributed to reducing TPR with high specificity. Integrating
the NA and mBCT into IPC protocols led to a decrease in CPB rectal carriage
prevalence in general wards, underscoring their diagnostic, epidemiological and
thus IPC benefits.
Description: 
Fil: Maximiliano Gabriel Castro. Internal Medicine Department. JB Iturraspe Hospital. Santa Fe; Argentina.

Fil: Maximiliano Gabriel Castro. Medical Sciences Faculty. National University of the Littoral. Santa Fe; Argentina.

Fil: Fernanda Argarañá. Microbiology Laboratory. JB Iturraspe Hospital. Santa Fe; Argentina.

Fil: Fernanda Argarañá. Biochemistry and Biological Sciences Faculty. National University of the Littoral.
Santa Fe; Argentina.

Fil: Carla Bernasconi. Microbiology Laboratory. JB Iturraspe Hospital. Santa Fe; Argentina.

Fil: Leticia Margenet. Microbiology Laboratory. JB Iturraspe Hospital. Santa Fe; Argentina.

Fil: Ana Paula Amato. Internal Medicine Department. JB Iturraspe Hospital. Santa Fe; Argentina.

Fil: Joaquín Ignacio Coduri Anthonioz Blanc. Internal Medicine Department. JB Iturraspe Hospital. Santa Fe; Argentina.

Fil: Erwin Alexander Rottoli. Internal Medicine Department. JB Iturraspe Hospital. Santa Fe; Argentina.

Fil: Manuel Protto. Internal Medicine Department. JB Iturraspe Hospital. Santa Fe; Argentina.

Fil: Macarena Vicino. Internal Medicine Department. JB Iturraspe Hospital. Santa Fe; Argentina.

Fil: María José Sadonio. Internal Medicine Department. JB Iturraspe Hospital. Santa Fe; Argentina.

Fil: Federico Rafael Galluccio. Internal Medicine Department. JB Iturraspe Hospital. Santa Fe; Argentina.

Fil: Federico Rafael Galluccio. Medical Sciences Faculty. National University of the Littoral. Santa Fe; Argentina.

Fil: Héctor Mario Musacchio. Internal Medicine Department. JB Iturraspe Hospital. Santa Fe; Argentina.

Fil: Héctor Mario Musacchio. Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Santa
Fe, Argentina.

Fil: Fernando Pasterán. Servicio Antimicrobianos. Instituto Nacional de Enfermedades Infecciosas (INEI) - ANLIS
“Dr. Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires; Argentina.

Fil: Sonia Alejandra Gómez. Servicio Antimicrobianos. Instituto Nacional de Enfermedades Infecciosas (INEI) - ANLIS
“Dr. Carlos G. Malbran”. Ciudad Autónoma de Buenos Aires; Argentina.
URI: http://sgc.anlis.gob.ar/handle/123456789/2695
DOI: 10.3389/fphar.2025.1584646
Appears in Collections:Publicaciones INEI

Files in This Item:
File Description SizeFormat
fphar-16-1584646.pdf1.4 MBAdobe PDFView/Open
Show full item record

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.